Clinical Indications: Semaglutide: Approved for both type 2 diabetes and chronic weight management in adults with obesity
The National Health Service (NHS) continues to promote evidence-based interventions, creating a favorable setting for the wider adoption of GLP-1 drugs
Our prescription options, such as Wegovy, Oral Wegovy, Zepbound, and Foundayo, are specifically approved for weight management
However, individual responses can vary
As a thyroid hormone receptor agonist, resmetirom improves hepatic steatosis, inflammation, and fibrosis while providing lipid and cardiovascular benefits
Ro remains a credible, brand-name-only choice, especially for patients who want insurance navigation support